Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson, M. R., Bucana, C. D., McConkey, D. J., McMahon, G., and Ellis, L. M. “Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.” Cancer Res., 59: 5412-5416, 1999. External Link Learn More Liu, W., Davis, D.W., Ramirez, K., McConkey, D.J., and Ellis, L.M. “Endothelial Cell Apoptosis is Inhibited by a Soluble Factor Secreted by Human Colon Cancer Cells.” Int. J. Cancer, 92:26-30, 2001. External Link Learn More McConkey, D.J., Davis, D.W. “Apoptosis and taxol therapy.” Cancer Biol Ther. 2002 Mar-Apr;1(2):118-20. External Link Learn More Herbst R.S., Mullani N.A., Davis D.W., Hess K.R., McConkey D.J., Charnsangavej C., OReilly M.S., Kim H.W., Baker, C., Roach, J., Ellis L.M., Rashid, A., Pluda J., Bucana, C., Madden, T.L., Tran, H.T., Abbruzzese J.L. ” Development of Biologic Markers of Response and Assessment of Antiangiogenic Activity in a Clinical Trial of Human Recombinant Endostatin.” J Clin Oncol. 2002 Sep 15;20(18):3804-14. External Link Learn More Davis DW, Buchholz TA, Hess KR, Sahin AA, Valero V, McConkey DJ. “Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response.” Clin Cancer Res. 2003 Mar;9(3):955-60. External Link Learn More Davis, D.W., McConkey, D.J., Wei Zhang, Herbst, R.S. “Antiangiogenic Tumor Therapy.” Antiangiogenic tumor therapy. Biotechniques. 2003 May;34(5):1048-50, 1052, 1054 passim. Review. External Link Learn More Davis, D.W., McConkey, D.J., Abbruzzese, J.L., Herbst, R.S. “Surrogate markers in antiangiogenesis clinical trials.” Br J Cancer. 2003 Jul 7;89(1):8-14. Review. External Link Learn More Davis, D.W., Shen, Y., Mullani, N.A., Wen, S., Herbst, R.S., OReilly, M.S., Abbruzzese, J.L., McConkey, D.J. “Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors.” Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):33-42. External Link Learn More Davis DW, Inoue K, Dinney CP, Hicklin DJ, Abbruzzese JL, McConkey DJ. ” Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts.” Cancer Res. 2004 Jul 1;64(13):4601-10. External Link Learn More Heymach JV, Desai J, Manola J, Davis DW, McConkey DJ, Harmon D, Ryan DP, Goss G, Quigley T, Van den Abbeele AD, Silverman SG, Connors S, Folkman J, Fletcher CD, Demetri GD. ” Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas.” Clin Cancer Res. 2004 Sep 1;10(17):5732-40. External Link Learn More 1 2 3 Next